XBI241227C98500
- 0.05
- 0.000.00%
SPDR S&P Biotech ETF Newsroom
Bulls Vs. Bears: Is the Schwab U.S. Dividend Equity ETF a Good Investment?
17 Analysts Assess Biogen: What You Need To Know
Piper Sandler Downgrades Biogen to Neutral, Lowers Price Target to $138
Biogen Analyst Ratings
Analyst Expectations For Amgen's Future
Amgen Analyst Ratings
How Is The Market Feeling About United Therapeutics?
Top U.S. Health Care Mid-cap Stocks and Their Quant Ratings
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Why Did Pfizer's Exit From the Gene Therapy Program Hit Sangamo Hard?
Trim the Mag 7 and Invest in Lower Valuation Dividend Growth Stocks – Miramar Capital
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
Weekly Buzz: So far, Santa is Letting us Down
Bristol-Myers Squibb's Opdivo Qvantig Gets US FDA Approval
Looking At Amgen's Recent Unusual Options Activity
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
Top Dividend Picks for 2025 According to Seeking Alpha's Quant Metrics
10 Health Care Stocks With Whale Alerts In Today's Session
Assembly Bio Spikes After Early-stage Data for Gilead-partnered Hep B Therapy